Health2Sync and Novo Nordisk Pharma Korea, Ltd. Launch Smart Cap Mallya® for FlexTouch® Insulin Pens Integration in South Korea, Enhancing insulin administration via Digital Diabetes Care
Media OutReach Newswire 
This innovation comes at a critical moment. Managing insulin administration records is a challenging task for both diabetes patients and healthcare professionals. In fact, a multinational survey of diabetes patients receiving insulin treatment and physicians treating diabetes patients found that 27.6% of patients experience difficulty administering insulin at the prescribed time or with meals. In the same study, 54.5% of physicians reported that their patients experience difficulty administering insulin at the prescribed time or with meals.
Mallya®, when paired with Health2Sync’s connected ecosystem, significantly lowers this burden. Patients using FlexTouch® insulin pens can now have their dosage, time, and frequency data recorded and visualized in real time within the SugarGenie app.
“This integration is connecting yet another integral part in digital diabetes care,” said Ed Deng, CEO and Co-founder of Health2Sync. “By connecting the data of Mallya® to SugarGenie, we’re improving accuracy in insulin tracking and expanding the depth of data available to patients and care teams. Our platform enables insulin logs to be viewed alongside blood glucose, meals, and physical activity, offering a full circle understanding of each patient’s health context.”
Deng continued: “For healthcare professionals, this means faster, smarter decisions. Our care provider portal lets clinicians view real-time patient data We’re turning disconnected data points into a unified, actionable picture of care, without placing additional burden on patients.”
SugarGenie’s integration with Mallya® supports remote care models and automated record-keeping—an increasingly critical combination for long-term chronic condition management in South Korea. With its clean interface, real-time sync, and care team dashboard, SugarGenie is a key digital infrastructure in Korea’s diabetes treatment landscape.
“Digital healthcare has become a key tool in enhancing the efficiency and convenience of diabetes treatment,” said Kasper Roseeuw Poulsen, General Manager of Novo Nordisk Pharma Korea, Ltd.. “For over a century, Novo Nordisk has supported patients through holistic solutions, and our collaboration with Health2Sync is also a continuation of that commitment. We hope this strategic collaboration will help create a more systematic and efficient treatment environment for both patients and healthcare professionals in Korea.”
Hashtag: #health2sync #diabetesmanagement #digitaltherapeutis #digitalhealth
https://www.health2sync.com/
https://www.linkedin.com/company/health2sync/
The issuer is solely responsible for the content of this announcement.
Health2Sync
Founded in 2013, Health2Sync is a leading digital health company in Asia focused on delivering personalized and comprehensive solutions for chronic disease management. Its core offerings include a mobile patient app and a cloud-based analytics platform for healthcare providers, designed to drive measurable improvements in blood glucose outcomes.
With the most extensive clinical network in Asia, Health2Sync offers a scalable, data-driven approach to diabetes care. The platform empowers patients with tailored insights, enabling healthcare professionals and caregivers to support them remotely and fostering continuous, collaborative care throughout the entire treatment journey.
For more information, please visit https://www.health2sync.com/ko.
About SugarGenie App
Health2Sync’s SugarGenie app collects biometric information measured by medical devices and transmits it to a platform via encrypted protocols, allowing patient data to be shared with family, caregivers, and healthcare institutions.5 It integrates data such as blood glucose level, blood pressure, weight, and user-inputted dietary and exercise information. It transforms it into visual reports to provide personalized feedback, enable effective communication between patients and healthcare professionals, and monitor real-time health status. As of June 2025, Health2Sync has over 1.5 million users worldwide.
